Skip to main content
. 2010 Mar 23;25(4-5):419–424. doi: 10.1159/000303046

Table 1.

Atrial action potential parameters in response to blebbistatin. C: control; B: blebbistatin; CL: cycle length (msec); MDP: maximum diastolic potential (mV); Pmax: maximum upstroke velocity (mV/msec); AP10, AP50 or AP90: action potential duration to 10%, 50% or 90% of repolarization (msec); ERP: effective refractory period (msec). Values are mean ± SEM.

luM (n=4) 5uM (n=4) 10uM (n=4)
C B P C B P C B P
CL 1254 ± 262 1366 ± 164 0.40 1110 ± 127 1139 ± 106 0.64 1040 ± 125 1163 ± 181 0.18
MDP −58.9 ± 1.4 −592 ± 2.6 0.81 −52.6 ± 6.3 −53.6 ± 5.0 0.49 −56.2 ± 6.2 −55.7 ± 6.2 0.41
Pmax 5.1 ± 1.4 4.6 ± 1.2 0.28 4.5 ± 0.8 4.3 ± 1.6 0.23 5.6 ± 1.6 4.8 ± 1.0 0.30
AP10 104.3 ± 15.7 115.7 ± 17.9 0.06 90.2 ± 7.2 88.8 ± 6.9 0.78 83.9 ± 7.7 81.8 ± 8.0 0.16
AP50 151.7 ± 20.3 129.0 ± 8.3 0.79 129.0 ± 8.3 126.9 ± 7.9 0.73 121.1 ± 11.8 118.6 ± 12.5 0.14
AP90 195.8 ± 31.4 190.9 ± 27.8 0.76 161.4 ± 15.2 159.8 ± 11.1 0.83 146.2 ± 14.1 146.3 ± 14.6 0.95
ERP 298 ± 13.1 301 ± 11.6 0.22